诊断生物芯片：创新和增长机会

对精准医疗和低成本即时诊断平台的巨大需求预计将推动诊断生物芯片市场。 创新的诊断生物芯片代表了基因检测、癌症诊断和治疗、传染病管理、慢性病管理、过敏面板测试、药物测试等的增长机会，因为它们可以检测不同类型的生物分子。。

本报告考察了全球诊断生物芯片市场，介绍了技术优势和挑战，分析了影响市场增长的各种因素、技术路线图、招聘趋势、资金、併购和专利。它总结了趋势、增长机会分析和更多的。

内容

战略要务

• 增长问题
• 战略要务 8 (TM)
• 三大战略要务的影响
• 增长机会推动增长PipelineEngine (TM)
• 调查方法

增长机会分析

• 用于小型和多种生物传感设备的诊断生物芯片
• 诊断生物芯片：新微阵列格式和製造技术的进展
• 生物芯片作为小型设备可实现高通量测试
• 生物芯片的许多用途
• 分类
• 诊断生物芯片行业的增长动力：对个性化医疗的需求不断增加
• 制约诊断生物芯片行业发展的因素：成本高
• 诊断生物芯片行业：一个不断增长且分散的市场
• 分析范围

技术分析：DNA 生物芯片

• DNA 生物芯片能够检测疾病的遗传生物标誌物
• 旨在降低设备成本的新型 DNA 生物芯片製造技术
• 诊断性 DNA 生物芯片：对生物标誌物发现的重大影响
• DNA 生物芯片：竞争格局

技术分析：蛋白质生物芯片

• 用于蛋白质分析、疾病生物标誌物检测和蛋白质功能鑑定的蛋白质生物芯片
• 专注于高灵敏度和固定化效率的新型蛋白质生物芯片製造技术
• 诊断性蛋白质生物芯片：对生物标誌物发现的重大影响
• 蛋白质生物芯片：竞争格局

技术分析：微流控生物芯片

• 用于 POC 疾病诊断的微流体生物芯片
• 专注于高通量生产的新型微流控生物芯片製造技术
• 诊断性微流体生物芯片：对核酸和蛋白质生物标誌物鑑定的重大影响
• 微流体生物芯片：竞争格局

创新指数

• 微流体诊断生物芯片部门：展示先进技术的发展和采用趋势
• 微流控生物芯片的低成本和便携性吸引了研究
• 用于低成本多路復用 LOC 设备的微流体
• 诊断生物芯片技术在体内连续监测设备方面取得进展
• 微流体生物芯片：便携性、成本效益和易于製造
• 近期併购活动分析：2019-2022 年
• 政府资金分析：2019-2022 年
• 私人筹款活动概况：2019-2022 年

专利分析

增长机会领域

• 发展机会 1：分子电子学
• 增长机会 2：微电极点阵 (MEDA) 生物芯片
• 增长机会 3：智能生物芯片平台

主要行业参与者

附录

下一步

Rapidly Evolving Microfluidic Biochips Enable Low-cost Point-of-care Diagnostics

Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments. To overcome this need, diagnostic biochip technology offers a miniaturized multiplexing sensing platform. A biochip is a solid substrate with a multitude of miniaturized test sites that have immobilized probes to capture and detect the target biomolecules. While biochips can have several applications, current research focuses on diagnostic biochips.

The huge demand for precision medicine and low-cost point-of-care diagnostic platforms will drive the market. However, key players must focus on reducing the costs of DNA and protein biochips, meeting regulatory standards, and increasing awareness among users.

The global diagnostic biochips industry is advancing, offering new fluidic control technologies, probe immobilization techniques, signal detection technologies, and data analytics. As they can detect different kinds of biomolecules, innovative diagnostic biochips provide growth opportunities for genetic testing, cancer diagnostics and therapy, infectious diseases management, chronic disease management, allergy panel testing, and drug testing. This study focuses on DNA biochips, protein biochips, and microfluidic biochips.

The key elements of this analysis include an overview of the global diagnostic biochips industry supported by the following:

• Technology advantages and disadvantages
• Industry growth drivers and restraints
• Key participants in different industry segments
• Technology roadmap
• SWOT analysis of diagnostic biochips
• Adoption, funding, and M&A trends
• Impact of the different technology segments
• Patent filing trends
• Growth opportunities for key companies

Table of Contents

Strategic Imperatives

• Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Diagnostic Biochips Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™
• Research Methodology

Growth Opportunity Analysis

• Diagnostic Biochips for Miniature and Multiplexing Biosensing Devices
• Diagnostic Biochips Are Advancing with New Microarray Formats and Fabrication Technologies
• Biochips as Miniature Devices Enable High-throughput Testing
• Biochips Have a Multitude of Applications
• Segmentation
• Increasing Demand for Personalized Medicine as a Growth Driver for Diagnostic Biochips Industry
• High Costs as a Growth Restraint for Diagnostic Biochips Industry
• Diagnostic Biochips Industry as a Growing and Fragmented Market
• Scope of Analysis

Technology Analysis: DNA Biochips

• DNA Biochips Enabling Detection of Genetic Biomarkers of Disease
• Emerging DNA Biochip Fabrication Technologies Aiming for Low Device Costs
• Diagnostic DNA Biochips Have High Impact on Biomarkers Discovery
• DNA Biochips-Competitive Environment
• DNA Biochips-Competitive Environment (continued)

Technology Analysis: Protein Biochips

• Protein Biochips for Protein Profiling, Disease Biomarkers Detection, and Protein Functions Identification
• Emerging Protein Biochip Fabrication Technologies Focusing on High Sensitivity and Immobilization Efficiency
• Diagnostic Protein Biochips Have High Impact on Biomarkers Discovery
• Protein Biochips-Competitive Environment
• Protein Biochips-Competitive Environment (continued)

Technology Analysis: Microfluidic Biochips

• Microfluidic Biochips for Disease Diagnosis at POC
• Emerging Microfluidic Biochip Fabrication Technologies Focusing on High-throughput Production
• Diagnostic Microfluidic Biochips Have High Impact on Identification of Nucleic Acid and Protein Biomarkers
• Microfluidic Biochips-Competitive Environment
• Microfluidic Biochips-Competitive Environment (continued)
• Microfluidic Biochips-Competitive Environment (continued)

Innovation Indicators

• Microfluidic Diagnostic Biochips Segment Exhibits High Technology Evolution and Adoption Trends
• Low Cost and Portability of Microfluidic Biochips Attracting Research
• Microfluidics for Low-cost Multiplexing LOC Devices
• Diagnostic Biochip Technology Advancing toward In Vivo Continuous Monitoring Devices
• Microfluidic Biochips Excel in Portability, Cost Efficiency, and Ease of Fabrication
• Recent M&A Activity Analysis, 2019-2022
• Government Funding Analysis, 2019-2022
• Private Funding Activities Snapshot, 2019-2022
• Private Funding Activities Snapshot, 2019-2022 (continued)

Patent Analysis

• Innovation Themes Include Microfluidic and Microarray Designs and Data Processing Technologies
• Key Patents
• Key Patents (continued)
• Key Patents (continued)

Growth Opportunity Universe

• Growth Opportunity 1: Molecular Electronics
• Growth Opportunity 1: Molecular Electronics (continued)
• Growth Opportunity 2: Micro-electrode-dot Array (MEDA) Biochips
• Growth Opportunity 2: MEDA Biochips (continued)
• Growth Opportunity 3: Intelligent Biochip Platform
• Growth Opportunity 3: Intelligent Biochip Platform (continued)

Key Industry Participants

• Database of Key Industry Participants

Appendix

• Technology Readiness Levels (TRL): Explanation

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• Legal Disclaimer